Suppressing Lynx1 helps brain recovery after stroke in mice

Reducing Lynx1 levels can improve the effectiveness of rehabilitation during the chronic phase after a stroke.

Researchers found that suppressing Lynx1 reopens a window for effective rehabilitation after a stroke in mice. This suppression improves spontaneous motor recovery and helps rehabilitation work better during the chronic phase.

Scientists used a focal ischemic stroke mouse model to study why rehabilitation efficacy decreases during the transition from the subacute to the chronic phase. They identified Lynx1 as a negative regulator of post-stroke neural plasticity.

Lynx1 is an endogenous negative allosteric modulator of nicotinic acetylcholine receptors. Neural plasticity is a process that declines during the transition to the chronic phase. The molecular and cellular mechanisms regulating these changes remain unclear.

Lynx1 expression in layer 5 pyramidal neurons was transiently down-regulated and then returned to normal levels in the peri-infarct area. Suppressing Lynx1 promoted synaptic clustering and increased dendritic spine turnover in that area.

Dendritic spine dynamics in the peri-infarct area may be a key determinant of rehabilitation responsiveness. Researchers developed a Lynx1-targeting antisense oligonucleotide to enhance rehabilitation efficacy during the chronic phase.

Lynx1 may represent a promising therapeutic target for augmenting dendritic plasticity after stroke.

Key facts

  • Lynx1 suppression promotes synaptic clustering and increased dendritic spine turnover.
  • A Lynx1-targeting antisense oligonucleotide enhanced rehabilitation efficacy in the chronic phase.
  • Lynx1 acts as a negative regulator of post-stroke neural plasticity.

All sections

Edition